Possible role of endothelin in the pathogenesis of cerebral vasospasm

T. Shigeno, T. Mima, Masashi Yanagisawa, A. Saito, A. Fujimori, R. Shiba, K. Goto, S. Kimura, K. Yamashita, Y. Yamasaki, T. Masaki, K. Takakura

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Since the discovery of endothelin-1 (ET-1), its involvement in cerebral vasospasm after subarachnoid hemorrhage (SAH) has been suspected. We performed various experiments, first to demonstrate the presence of ET in both patients and dogs with SAH, and second to examine the effects of ET synthesis inhibition in experimental vasospasm. Here we report that ET was present in both plasma and cerebrospinal fluid (CSF) in SAH, but did not correlate with vasospasm. However, ET was locally expressed in the vascular endothelium in vasospasm. Several therapeutic approaches causing the inhibition of ET synthesis were effective in preventing the development of vasospasm. Such approaches utilized drugs that inhibited RNA and DNA synthesis. Among them, actinomycin D treatment was most effective. We also utilized phosphoramidon, a recently found conversion inhibitor of big ET to ET. However, this product failed to ameliorate the development of vasospasm. Therefore, although we cannot yet conclude that ET is the main cause of cerebral vasospasm, it may, at least, act as one of the modifying factors in cerebral vasospasm.

Original languageEnglish (US)
JournalJournal of Cardiovascular Pharmacology
Volume17
Issue numberSUPPL. 7
StatePublished - 1991

Fingerprint

Intracranial Vasospasm
Endothelins
Subarachnoid Hemorrhage
Vascular Endothelium
Dactinomycin
Endothelin-1
Cerebrospinal Fluid
Dogs
RNA
DNA
Therapeutics
Pharmaceutical Preparations

Keywords

  • Actinomycin D
  • Cerebral vasospasm
  • Endothelin
  • Phosphoramidon
  • RNA synthesis

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Pharmacology

Cite this

Shigeno, T., Mima, T., Yanagisawa, M., Saito, A., Fujimori, A., Shiba, R., ... Takakura, K. (1991). Possible role of endothelin in the pathogenesis of cerebral vasospasm. Journal of Cardiovascular Pharmacology, 17(SUPPL. 7).

Possible role of endothelin in the pathogenesis of cerebral vasospasm. / Shigeno, T.; Mima, T.; Yanagisawa, Masashi; Saito, A.; Fujimori, A.; Shiba, R.; Goto, K.; Kimura, S.; Yamashita, K.; Yamasaki, Y.; Masaki, T.; Takakura, K.

In: Journal of Cardiovascular Pharmacology, Vol. 17, No. SUPPL. 7, 1991.

Research output: Contribution to journalArticle

Shigeno, T, Mima, T, Yanagisawa, M, Saito, A, Fujimori, A, Shiba, R, Goto, K, Kimura, S, Yamashita, K, Yamasaki, Y, Masaki, T & Takakura, K 1991, 'Possible role of endothelin in the pathogenesis of cerebral vasospasm', Journal of Cardiovascular Pharmacology, vol. 17, no. SUPPL. 7.
Shigeno, T. ; Mima, T. ; Yanagisawa, Masashi ; Saito, A. ; Fujimori, A. ; Shiba, R. ; Goto, K. ; Kimura, S. ; Yamashita, K. ; Yamasaki, Y. ; Masaki, T. ; Takakura, K. / Possible role of endothelin in the pathogenesis of cerebral vasospasm. In: Journal of Cardiovascular Pharmacology. 1991 ; Vol. 17, No. SUPPL. 7.
@article{d60799d1508142ffb74acd3a33b23a29,
title = "Possible role of endothelin in the pathogenesis of cerebral vasospasm",
abstract = "Since the discovery of endothelin-1 (ET-1), its involvement in cerebral vasospasm after subarachnoid hemorrhage (SAH) has been suspected. We performed various experiments, first to demonstrate the presence of ET in both patients and dogs with SAH, and second to examine the effects of ET synthesis inhibition in experimental vasospasm. Here we report that ET was present in both plasma and cerebrospinal fluid (CSF) in SAH, but did not correlate with vasospasm. However, ET was locally expressed in the vascular endothelium in vasospasm. Several therapeutic approaches causing the inhibition of ET synthesis were effective in preventing the development of vasospasm. Such approaches utilized drugs that inhibited RNA and DNA synthesis. Among them, actinomycin D treatment was most effective. We also utilized phosphoramidon, a recently found conversion inhibitor of big ET to ET. However, this product failed to ameliorate the development of vasospasm. Therefore, although we cannot yet conclude that ET is the main cause of cerebral vasospasm, it may, at least, act as one of the modifying factors in cerebral vasospasm.",
keywords = "Actinomycin D, Cerebral vasospasm, Endothelin, Phosphoramidon, RNA synthesis",
author = "T. Shigeno and T. Mima and Masashi Yanagisawa and A. Saito and A. Fujimori and R. Shiba and K. Goto and S. Kimura and K. Yamashita and Y. Yamasaki and T. Masaki and K. Takakura",
year = "1991",
language = "English (US)",
volume = "17",
journal = "Journal of Cardiovascular Pharmacology",
issn = "0160-2446",
publisher = "Lippincott Williams and Wilkins",
number = "SUPPL. 7",

}

TY - JOUR

T1 - Possible role of endothelin in the pathogenesis of cerebral vasospasm

AU - Shigeno, T.

AU - Mima, T.

AU - Yanagisawa, Masashi

AU - Saito, A.

AU - Fujimori, A.

AU - Shiba, R.

AU - Goto, K.

AU - Kimura, S.

AU - Yamashita, K.

AU - Yamasaki, Y.

AU - Masaki, T.

AU - Takakura, K.

PY - 1991

Y1 - 1991

N2 - Since the discovery of endothelin-1 (ET-1), its involvement in cerebral vasospasm after subarachnoid hemorrhage (SAH) has been suspected. We performed various experiments, first to demonstrate the presence of ET in both patients and dogs with SAH, and second to examine the effects of ET synthesis inhibition in experimental vasospasm. Here we report that ET was present in both plasma and cerebrospinal fluid (CSF) in SAH, but did not correlate with vasospasm. However, ET was locally expressed in the vascular endothelium in vasospasm. Several therapeutic approaches causing the inhibition of ET synthesis were effective in preventing the development of vasospasm. Such approaches utilized drugs that inhibited RNA and DNA synthesis. Among them, actinomycin D treatment was most effective. We also utilized phosphoramidon, a recently found conversion inhibitor of big ET to ET. However, this product failed to ameliorate the development of vasospasm. Therefore, although we cannot yet conclude that ET is the main cause of cerebral vasospasm, it may, at least, act as one of the modifying factors in cerebral vasospasm.

AB - Since the discovery of endothelin-1 (ET-1), its involvement in cerebral vasospasm after subarachnoid hemorrhage (SAH) has been suspected. We performed various experiments, first to demonstrate the presence of ET in both patients and dogs with SAH, and second to examine the effects of ET synthesis inhibition in experimental vasospasm. Here we report that ET was present in both plasma and cerebrospinal fluid (CSF) in SAH, but did not correlate with vasospasm. However, ET was locally expressed in the vascular endothelium in vasospasm. Several therapeutic approaches causing the inhibition of ET synthesis were effective in preventing the development of vasospasm. Such approaches utilized drugs that inhibited RNA and DNA synthesis. Among them, actinomycin D treatment was most effective. We also utilized phosphoramidon, a recently found conversion inhibitor of big ET to ET. However, this product failed to ameliorate the development of vasospasm. Therefore, although we cannot yet conclude that ET is the main cause of cerebral vasospasm, it may, at least, act as one of the modifying factors in cerebral vasospasm.

KW - Actinomycin D

KW - Cerebral vasospasm

KW - Endothelin

KW - Phosphoramidon

KW - RNA synthesis

UR - http://www.scopus.com/inward/record.url?scp=0026349274&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026349274&partnerID=8YFLogxK

M3 - Article

VL - 17

JO - Journal of Cardiovascular Pharmacology

JF - Journal of Cardiovascular Pharmacology

SN - 0160-2446

IS - SUPPL. 7

ER -